Safety and Efficacy of GW685698X an Inhaled Corticosteroid Once Daily and Twice Daily for the Treatment of Asthma

Completed · Phase 2

Conditions studied: Asthma

In brief

The purpose of this study is to compare once and twice daily GW685698 in asthma

Key facts

Study ID

NCT00766090

Run by

GlaxoSmithKline

People needed

190

Starts

2008-10-01

Expected to finish

2009-03-01

Last updated by the study team

2016-12-08

Who can join

Age: 12 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• GSK Investigational Site — Long Beach, California, United States
• GSK Investigational Site — Long Beach, California, United States
• GSK Investigational Site — Torrance, California, United States
• GSK Investigational Site — Cocoa, Florida, United States
• GSK Investigational Site — Tallahassee, Florida, United States
• GSK Investigational Site — Bethesda, Maryland, United States
• GSK Investigational Site — Columbia, Missouri, United States
• GSK Investigational Site — Rolla, Missouri, United States
• GSK Investigational Site — Raleigh, North Carolina, United States
• GSK Investigational Site — Canton, Ohio, United States
• GSK Investigational Site — Medford, Oregon, United States
• GSK Investigational Site — Orangeburg, South Carolina, United States
• GSK Investigational Site — Austin, Texas, United States
• GSK Investigational Site — Boerne, Texas, United States
• GSK Investigational Site — San Antonio, Texas, United States
• GSK Investigational Site — Waco, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.